Literature DB >> 4936286

Inability of the NZB-NZW F 1 thymus to transfer cyclophosphamide-induced tolerance to sheep erythrocytes.

M E Jacobs, J K Gordon, N Talal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4936286

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Independent appearance of anti-thymocyte and anti-RNA antibodies in NZB/NZW F1 mice.

Authors:  R Goldblum; R Pillarisetty; N Talal
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

2.  Leucocyte migration-inhibition in systemic lupus erythematosus.

Authors:  P Hughes; S Holt; N R Rowell
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

3.  Alteration in DNA synthetic response of thymocytes from NZB mice of different ages.

Authors:  M J Dauphinee; N Talal
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Normal tolerance characteristics of the antibody-forming cell precursors of the NZB mouse.

Authors:  E C Purves; J H Playfair
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

5.  The pathogenesis of autoimmunity in New Zealand mice. IV. Independent stimulation of antibodies to DNA and RNA.

Authors:  D E Powell; A D Steinberg
Journal:  Clin Exp Immunol       Date:  1972-11       Impact factor: 4.330

6.  Age-related decline in the antibody response to E. coli lipopolysaccharide in New Zealand Black mice.

Authors:  M J Blankwater; L A Levert; W Hijmans
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

7.  Thymosin corrects the abnormal DNA synthetic response of NZB mouse thymocytes.

Authors:  M J Dauphinee; N Talal; A L Goldstein; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

8.  Defective B cell tolerance in adult (NZB X MZW)F1 mice.

Authors:  E A Goldings; P L Cohen; S F McFadden; M Ziff; E S Vitetta
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.